Wilding and his colleagues [Reference ONeil, Aroda, Astrup, Kushner, Lau and Wadden7] conducted a comprehensive analysis by combining data from various weight-management clinical trials [Reference Blackman, Foster, Zammit, Rosenberg, Aronne and Wadden22Reference Wadden, Hollander, Klein, Niswender, Woo and Hale27], focusing on the neuropsychiatric safety of liraglutide
Extensive animal studies have demonstrated its remarkable ability to accelerate the healing of diverse wounds, including those affecting muscles, tendons, and ligaments
Evidence that many people may stop their use of obesity drugs not long after starting therapy casts doubt about the sustainability of weight loss to achieve long-term positive health outcomes
Using mice for the study, the researchers found that heart muscle also decreased in both obese and lean mice
Basic science and careful clinical trials gave us what appears to be, for many, a wonder drug